{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T01:06:47Z","timestamp":1790384807820,"version":"4.1.0"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100012553","name":"Chang Gung Memorial Hospital","doi-asserted-by":"publisher","award":["CMRPG3H0911"],"award-info":[{"award-number":["CMRPG3H0911"]}],"id":[{"id":"10.13039\/100012553","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012553","name":"Chang Gung Memorial Hospital","doi-asserted-by":"publisher","award":["CMRPG3I0021"],"award-info":[{"award-number":["CMRPG3I0021"]}],"id":[{"id":"10.13039\/100012553","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012553","name":"Chang Gung Memorial Hospital","doi-asserted-by":"publisher","award":["CMRPG3H0361"],"award-info":[{"award-number":["CMRPG3H0361"]}],"id":[{"id":"10.13039\/100012553","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["106-2314-B-182A-123-MY3"],"award-info":[{"award-number":["106-2314-B-182A-123-MY3"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.cca.2019.03.1623","type":"journal-article","created":{"date-parts":[[2019,3,21]],"date-time":"2019-03-21T03:44:51Z","timestamp":1553139891000},"page":"143-150","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Whole-exome sequencing detects mutations in pediatric patients with atypical hemolytic uremic syndrome in Taiwan"],"prefix":"10.1016","volume":"494","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4560-9429","authenticated-orcid":false,"given":"Min-Hua","family":"Tseng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeng-Daw","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I-Jung","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shih-Ming","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing-Long","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Lang","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hwei-Jen","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tai-Wei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shih-Hua","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"17","key":"10.1016\/j.cca.2019.03.1623_bb0005","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1056\/NEJMra0902814","article-title":"Atypical hemolytic-uremic syndrome","volume":"361","author":"Noris","year":"2009","journal-title":"N. Engl. J. Med."},{"issue":"10","key":"10.1016\/j.cca.2019.03.1623_bb0010","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.2215\/CJN.02210310","article-title":"Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype","volume":"510","author":"Noris","year":"2010","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"6","key":"10.1016\/j.cca.2019.03.1623_bb0015","doi-asserted-by":"crossref","first-page":"E1445","DOI":"10.1002\/humu.21256","article-title":"Mutations in alternative pathway complement proteins in American patients with atypical hemolytic uremic syndrome","volume":"31","author":"Maga","year":"2010","journal-title":"Hum. Mutat."},{"issue":"4","key":"10.1016\/j.cca.2019.03.1623_bb0020","doi-asserted-by":"crossref","first-page":"554","DOI":"10.2215\/CJN.04760512","article-title":"Genetics and outcome of atypical hemolytic uremic syndrome: a nationwide French series comparing children and adults","volume":"8","author":"Fremeaux-Bacchi","year":"2013","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"3","key":"10.1016\/j.cca.2019.03.1623_bb0025","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1046\/j.1365-2249.1999.00917.x","article-title":"Elevated serum levels of soluble membrane cofactor protein (CD46, MCP) in patients with systemic lupus erythematosus (SLE)","volume":"116","author":"Kawano","year":"1999","journal-title":"Clin. Exp. Immunol."},{"issue":"5","key":"10.1016\/j.cca.2019.03.1623_bb0030","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s12185-014-1655-2","article-title":"Analysis of patients with atypical hemolytic uremic syndrome treated at the Mie University Hospital: concentration of C3 p.I1157T mutation","volume":"100","author":"Matsumoto","year":"2014","journal-title":"Int. J. Hematol."},{"issue":"11","key":"10.1016\/j.cca.2019.03.1623_bb0035","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/nrneph.2012.214","article-title":"French study group for aHUS\/C3G, use of eculizumab for atypical haemolytic uraemic syndrome and C3 glomerulopathies","volume":"8","author":"Zuber","year":"2012","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.cca.2019.03.1623_bb0040","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/1750-1172-6-60","article-title":"Atypical hemolytic uremic syndrome","volume":"6","author":"Loirat","year":"2011","journal-title":"Orphanet. J. Rare. Dis."},{"issue":"1","key":"10.1016\/j.cca.2019.03.1623_bb0045","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1182\/asheducation.V2012.1.617.3798924","article-title":"Atypical hemolytic uremic syndrome: what is it, how is it diagnosed, and how is it treated?","volume":"2012","author":"Nester","year":"2012","journal-title":"Hematology. Am. Soc. Hematol. Educ. Program."},{"issue":"14","key":"10.1016\/j.cca.2019.03.1623_bb0050","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","article-title":"Fast and accurate short read alignment with burrows-wheeler transform","volume":"25","author":"Li","year":"2009","journal-title":"Bioinformatics."},{"issue":"5","key":"10.1016\/j.cca.2019.03.1623_bb0055","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/ng.806","article-title":"A framework for variation discovery and genotyping using next-generation DNA sequencing data","volume":"43","author":"DePristo","year":"2011","journal-title":"Nat. Genet."},{"issue":"16","key":"10.1016\/j.cca.2019.03.1623_bb0060","doi-asserted-by":"crossref","first-page":"e164","DOI":"10.1093\/nar\/gkq603","article-title":"ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data","volume":"38","author":"Wang","year":"2010","journal-title":"Nucleic Acids Res."},{"issue":"13","key":"10.1016\/j.cca.2019.03.1623_bb0065","doi-asserted-by":"crossref","first-page":"3812","DOI":"10.1093\/nar\/gkg509","article-title":"SIFT: predicting amino acid changes that affect protein function","volume":"31","author":"Ng","year":"2003","journal-title":"Nucleic Acids Res."},{"issue":"4","key":"10.1016\/j.cca.2019.03.1623_bb0070","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nmeth0410-248","article-title":"A method and server for predicting damaging missense mutations","volume":"7","author":"Adzhubei","year":"2010","journal-title":"Nat. Methods"},{"issue":"9","key":"10.1016\/j.cca.2019.03.1623_bb0075","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1101\/gr.092619.109","article-title":"Identification of deleterious mutations within three human genomes","volume":"19","author":"Chun","year":"2009","journal-title":"Genome Res."},{"issue":"8","key":"10.1016\/j.cca.2019.03.1623_bb0080","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/nmeth0810-575","article-title":"MutationTaster evaluates disease-causing potential of sequence alterations","volume":"7","author":"Schwarz","year":"2010","journal-title":"Nat. Methods"},{"issue":"1","key":"10.1016\/j.cca.2019.03.1623_bb0085","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1002\/humu.22225","article-title":"Predicting the functional, molecular, and phenotypic consequences of amino acid substitutions using hidden Markov models","volume":"34","author":"Shihab","year":"2013","journal-title":"Hum. Mutat."},{"issue":"12","key":"10.1016\/j.cca.2019.03.1623_bb0090","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1038\/ng.3703","article-title":"M-CAP eliminates a majority of variants of uncertain significance in clinical exomes at high sensitivity","volume":"48","author":"Jagadeesh","year":"2016","journal-title":"Nat. Genet."},{"issue":"3","key":"10.1016\/j.cca.2019.03.1623_bb0095","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1038\/ng.2892","article-title":"A general framework for estimating the relative pathogenicity of human genetic variants","volume":"469","author":"Kircher","year":"2014","journal-title":"Nat. Genet."},{"issue":"12","key":"10.1016\/j.cca.2019.03.1623_bb0100","doi-asserted-by":"crossref","first-page":"e1001025","DOI":"10.1371\/journal.pcbi.1001025","article-title":"Identifying a high fraction of the human genome to be under selective constraint using GERP++","volume":"6","author":"Davydov","year":"2010","journal-title":"PLoS Comput. Biol."},{"issue":"46","key":"10.1016\/j.cca.2019.03.1623_bb0105","doi-asserted-by":"crossref","first-page":"19274","DOI":"10.1073\/pnas.0909755106","article-title":"Crystal structures of the noncatalytic domains of ADAMTS13 reveal multiple discontinuous exosits for von Willebrand factor","volume":"106","author":"Akiyama","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.cca.2019.03.1623_bb0110","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1110\/ps.073287008","article-title":"Crystal structures of the two major aggrecan degrading enzymes, ADAMTS4 and ADAMTS5","volume":"17","author":"Mosyak","year":"2008","journal-title":"Protein Sci."},{"issue":"4","key":"10.1016\/j.cca.2019.03.1623_bb0115","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s00467-008-0964-1","article-title":"European Paediatric Study Group for HUS. Guideline for the investigation and initial therapy of diarrhea-negative hemolytic uremic syndrome","volume":"24","author":"Ariceta","year":"2009","journal-title":"Pediatr. Nephrol."},{"issue":"5","key":"10.1016\/j.cca.2019.03.1623_bb0120","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1038\/ki.2014.423","article-title":"Efficacy and safety of eculizumab in atypical hemolytic uremic syndrome from 2-year extensions of phase 2 studies","volume":"87","author":"Licht","year":"2015","journal-title":"Kidney Int."},{"issue":"25","key":"10.1016\/j.cca.2019.03.1623_bb0125","doi-asserted-by":"crossref","first-page":"18244","DOI":"10.1016\/S0021-9258(19)37179-0","article-title":"CD36 peptides enhance or inhibit CD36-thrombospondin binding. A two-step process of ligand-receptor interaction","volume":"267","author":"Leung","year":"1992","journal-title":"J. Biol. Chem."},{"issue":"8","key":"10.1016\/j.cca.2019.03.1623_bb0130","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1007\/s00467-012-2131-y","article-title":"Atypical hemolytic uremic syndrome in children: complement mutations and clinical characteristics","volume":"27","author":"Geerdink","year":"2012","journal-title":"Pediatr. Nephrol."},{"issue":"8","key":"10.1016\/j.cca.2019.03.1623_bb0135","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1681\/ASN.2006080811","article-title":"Differential impact of complement mutations on clinical characteristics in atypical hemolytic uremic syndrome","volume":"18","author":"Sellier-Leclerc","year":"2007","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.cca.2019.03.1623_bb0140","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1186\/s12882-015-0195-1","article-title":"The global aHUS registry: methodology and initial patient characteristics","volume":"16","author":"Licht","year":"2015","journal-title":"BMC Nephrol."},{"issue":"13","key":"10.1016\/j.cca.2019.03.1623_bb0145","doi-asserted-by":"crossref","first-page":"4948","DOI":"10.1182\/blood-2008-01-133702","article-title":"Mutations in complement C3 predispose to development of atypical hemolytic uremic syndrome","volume":"112","author":"Fr\u00e9meaux-Bacchi","year":"2008","journal-title":"Blood."},{"issue":"3","key":"10.1016\/j.cca.2019.03.1623_bb0150","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1159\/000487609","article-title":"Atypical hemolytic uremic syndrome in children aged <2 years","volume":"139","author":"\u00c7akar","year":"2018","journal-title":"Nephron."},{"issue":"12","key":"10.1016\/j.cca.2019.03.1623_bb0155","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1007\/s00467-010-1606-y","article-title":"Neurological involvement in a child with atypical hemolytic uremic syndrome","volume":"25","author":"Koehl","year":"2010","journal-title":"Pediatr. Nephol."},{"issue":"12","key":"10.1016\/j.cca.2019.03.1623_bb0160","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1681\/ASN.2010030315","article-title":"Clinical features of anti-factor H autoantibody-associated hemolytic uremic syndrome","volume":"21","author":"Dragon-Durey","year":"2010","journal-title":"J. Am. Soc. Nephrol."},{"issue":"6","key":"10.1016\/j.cca.2019.03.1623_bb0165","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1093\/ndt\/gfq160","article-title":"Myocardial infarction is a complication of factor H-associated atypical HUS","volume":"25","author":"Sall\u00e9e","year":"2010","journal-title":"Nephrol. Dial. Tranplant."},{"issue":"5","key":"10.1016\/j.cca.2019.03.1623_bb0170","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1007\/s10157-018-1549-3","article-title":"Clinical characteristics and genetic backgrounds of Japanese patients with atypical hemolytic uremic syndrome","volume":"22","author":"Fujisawa","year":"2018","journal-title":"Clin. Exp. Nephrol."},{"issue":"6","key":"10.1016\/j.cca.2019.03.1623_bb0175","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.semnephrol.2013.08.003","article-title":"Atypical hemolytic uremic syndrome","volume":"33","author":"Kavanagh","year":"2013","journal-title":"Semin. Nephrol."},{"issue":"24","key":"10.1016\/j.cca.2019.03.1623_bb0180","doi-asserted-by":"crossref","first-page":"3733","DOI":"10.1182\/blood-2013-12-547067","article-title":"Biomarkers of terminal complement activation confirm the diagnosis of aHUS and differentiate aHUS from TTP","volume":"123","author":"Cataland","year":"2014","journal-title":"Blood."},{"issue":"11","key":"10.1016\/j.cca.2019.03.1623_bb0185","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1182\/blood-2014-02-558296","article-title":"Dynamics of complement activation in aHUS and how to monitor eculizumab therapy","volume":"124","author":"Noris","year":"2014","journal-title":"Blood."},{"issue":"3","key":"10.1016\/j.cca.2019.03.1623_bb0190","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1681\/ASN.2012090884","article-title":"Combined complement gene mutations in atypical hemolytic uremic syndrome influence clinical phenotype","volume":"24","author":"Bresin","year":"2013","journal-title":"J. Am. Soc. Nephrol."},{"issue":"24","key":"10.1016\/j.cca.2019.03.1623_bb0195","doi-asserted-by":"crossref","first-page":"3385","DOI":"10.1093\/hmg\/ddg363","article-title":"Complement factor H mutations and gene polymorphisms in haemolytic uraemic syndrome: the C-257T, the A2089G and the G2881T polymorphisms are strongly associated with the disease","volume":"12","author":"Caprioli","year":"2003","journal-title":"Hum. Mol. Genet."},{"issue":"3","key":"10.1016\/j.cca.2019.03.1623_bb0200","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1681\/ASN.2007080923","article-title":"The complement factor H R1210C mutation is associated with atypical hemolytic uremic syndrome","volume":"19","author":"Martinez-Barricarte","year":"2008","journal-title":"J. Am. Soc. Nephrol."},{"issue":"1","key":"10.1016\/j.cca.2019.03.1623_bb0205","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1681\/ASN.2013050453","article-title":"Comprehensive genetic analysis of complement and coagulation genes in atypical hemolytic uremic syndrome","volume":"25","author":"Bu","year":"2014","journal-title":"J. Am. Soc. Nephrol."},{"issue":"6","key":"10.1016\/j.cca.2019.03.1623_bb0210","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.2215\/CJN.08520814","article-title":"Characterization of a new Intronic mutation in genetically unsolved cases of familial atypical Hemolytic uremic syndrome","volume":"10","author":"Mele","year":"2015","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"26","key":"10.1016\/j.cca.2019.03.1623_bb0215","doi-asserted-by":"crossref","first-page":"2819","DOI":"10.1182\/blood-2017-04-780825","article-title":"Platelet interaction with activated endothelium-mechanistic insights from microfluidics","volume":"130","author":"Coenen","year":"2017","journal-title":"Blood."},{"issue":"4","key":"10.1016\/j.cca.2019.03.1623_bb0220","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1111\/j.1365-2141.1994.tb05131.x","article-title":"Anti-CD36 antibodies in patients with lupus anticoagulant and thrombotic complications","volume":"88","author":"Rock","year":"1994","journal-title":"Br. J. Haematol."},{"issue":"4","key":"10.1016\/j.cca.2019.03.1623_bb0225","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1111\/j.1365-2141.1994.tb05122.x","article-title":"Anti-CD36 antibodies in thrombotic thrombocytopenic purpura","volume":"88","author":"Tandon","year":"1994","journal-title":"Br. J. Haematol."},{"issue":"2","key":"10.1016\/j.cca.2019.03.1623_bb0230","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/j.1537-2995.2008.01978.x","article-title":"ADAMTS13 binds to CD36: a potential mechanism for platelet and endothelial localization of ADAMTS13","volume":"49","author":"Davis","year":"2009","journal-title":"Transfusion."},{"issue":"5","key":"10.1016\/j.cca.2019.03.1623_bb0235","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0177894","article-title":"Predictive features of chronic kidney disease in atypical hemolytic uremic syndrome","volume":"12","author":"Jamme","year":"2017","journal-title":"PLoS One"}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898119317280?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898119317280?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T21:36:33Z","timestamp":1778708193000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898119317280"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":47,"alternative-id":["S0009898119317280"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2019.03.1623","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Whole-exome sequencing detects mutations in pediatric patients with atypical hemolytic uremic syndrome in Taiwan","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2019.03.1623","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}